home All News open_in_new Full Article
Notice of Knight Therapeutics’ Fourth Quarter and Year End 2024 Results Conference Call
Knight Therapeutics Inc. (TSX: GUD) will release its Q4 and year-end 2024 financial results on March 20, 2025, prior to market opening, followed by a conference call and audio webcast. The call can be accessed toll-free at 1-888-699-1199 or internationally at 1-416-945-7677, with a webcast available at www.knighttx.com. An archived replay will be available for 30 days on the website. Knight Therapeutics is a pan-American (ex-USA) specialty pharmaceutical company.
today 19 h. ago attach_file Culture
attach_file
Economics
attach_file
Economics
attach_file
Culture
attach_file
Culture
attach_file
Culture
attach_file
Culture
attach_file
Culture
attach_file
Culture
attach_file
Culture
attach_file
Culture
attach_file
Culture
attach_file
Economics
attach_file
Culture
attach_file
Culture
attach_file
Culture
attach_file
Culture
ID: 370307537